(Q39815093)

14 September 2017

Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families (English)

1 reference

14 September 2017

1 reference

A S Monto

1

1 reference

14 September 2017

S A Schwartz

series ordinal

2

1 reference

14 September 2017

J K Albrecht

series ordinal

3

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 March 1989

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

33

1 reference

14 September 2017

3

1 reference

14 September 2017

387-390

1 reference

Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171498

Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171498

Prevention of Russian Influenza by Amantadine

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171498

Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171498

Statistical Procedures for Estimating the Community Probability of Illness in Family Studies: Rhinovirus and Influenza

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171498

Inhibition of respiratory virus infection by locally applied interferon

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171498

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171498

Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171498

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171498

Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose

20 August 2018

1 reference

12 December 2020

Prophylactic efficacy and tolerance of low-dose intranasal interferon-alpha 2 in natural respiratory viral infections

1 reference

12 December 2020

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

1 reference

12 December 2020

Intranasal interferon-alpha 2b for seasonal prophylaxis of respiratory infection

1 reference

12 December 2020

Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study

1 reference

12 December 2020

Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes

1 reference

12 December 2020

Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli

1 reference

12 December 2020

Intranasal Interferon 2 for Prevention of Rhinovirus Infection and Illness

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.33.3.387

1 reference

14 September 2017

1 reference

14 September 2017

PubMed publication ID

2543280

1 reference